Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-09-23 00:00:00 ET · period of report 2025-09-19 · accession 0001510281-25-000498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-09-23 | 2025-09-19+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.13 | -48.6K | 2.88M | -2% | -$687.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-22 | S | D | 41,623 | $14.14 | 2,837,633 | I - | — | — | |
| 2 | Common | Common Stock | 2025-09-19 | S | D | 6,989 | $14.10 | 2,879,256 | I - | — | — |